MilliporeSigma
  • Home
  • Search Results
  • Predictors of pathologic outcome of focal FDG uptake in the parotid gland identified on whole-body FDG PET imaging.

Predictors of pathologic outcome of focal FDG uptake in the parotid gland identified on whole-body FDG PET imaging.

Clinical imaging (2015-09-02)
Marc C Mabray, Spencer C Behr, David M Naeger, Robert R Flavell, Christine M Glastonbury
ABSTRACT

The purpose was to test whether patient's primary malignancy type and presence of F-18-fluorodeoxyglucose (FDG)-avid cervical lymph node(s) are predictors of pathologic outcome of incidental focal FDG-avid parotid lesions. A retrospective cohort study of pathologically proven incidental cases was performed. Focal parotid FDG uptake in the setting of head and neck cancer/melanoma [odds ratio (OR)=24.6, P<.01], lymphoma (OR=7.2, P=.02), or FDG-avid cervical lymph node(s) (OR=3.6, P=.07) has a higher odds of representing metastases. No malignant primary parotid tumors were incidentally discovered. In patients with head and neck cancer/melanoma, lymphoma, or FDG-avid cervical lymph node(s), there were higher odds that focal parotid FDG uptake was a metastasis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Histodenz, nonionic density gradient medium
Sigma-Aldrich
Tantalum(V) ethoxide, 99.98% trace metals basis
Tantalum(V) ethoxide, packaged for use in deposition systems